135 related articles for article (PubMed ID: 7467564)
1. [Drug therapy in renal failure].
Lachhein L
Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 38-40. PubMed ID: 7467564
[TBL] [Abstract][Full Text] [Related]
2. Consequences of renal insufficiency on the hepatic clearance of some drugs.
Balant LP; Dayer P; Fabre J
Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics in patients with renal failure.
Maher JF
Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
[TBL] [Abstract][Full Text] [Related]
4. [Renal insufficiency and drug metabolism].
Balant LP
Therapie; 1987; 42(4):393-7. PubMed ID: 3686475
[No Abstract] [Full Text] [Related]
5. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
6. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
Balant L; Gorgia A; Marmy A; Tschopp JM
Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic bases of dosage adaptation of drugs in renal insufficiency].
Lesne M
J Pharm Belg; 1988; 43(3):212-32. PubMed ID: 3171871
[No Abstract] [Full Text] [Related]
8. [Oral galactose loading in characterizing the elimination and metabolizing performance of the liver in chronic renal failure].
Otting U; Eggert S; Eggert W; Zoellner K; Buchali K
Z Urol Nephrol; 1987 Jun; 80(6):341-7. PubMed ID: 3307214
[TBL] [Abstract][Full Text] [Related]
9. [Retention of metabolites of a beta-blocking drug, oxprenolol, in renal insufficiency].
Dayer P; Glasson P; Gorgia A; Balant L; Fabre J
Schweiz Med Wochenschr; 1981 Dec; 111(49):1915-8. PubMed ID: 7330645
[TBL] [Abstract][Full Text] [Related]
10. [Practical aspects of pharmacokinetics in renal failure].
Orzechowska-Juzwenko K; Janicki AG
Pol Tyg Lek; 1982 Oct; 37(39):1181-4. PubMed ID: 7163064
[No Abstract] [Full Text] [Related]
11. [Introduction to the topic: drug dosage in renal insufficiency].
Sieberth HG
Internist (Berl); 1981 Oct; 22(10):597-600. PubMed ID: 7028661
[No Abstract] [Full Text] [Related]
12. [Pharmacokinetic and biological effective time of beta-receptor blockers in renal insufficiency].
Knauf H; Schäfer-Korting M; Mutschler E
Internist (Berl); 1981 Oct; 22(10):616-21. PubMed ID: 6117538
[No Abstract] [Full Text] [Related]
13. [Pharmacotherapy in severe liver failure].
Hruby K; Kleinberger G
Leber Magen Darm; 1982 Oct; 12(5):188-92. PubMed ID: 7182698
[TBL] [Abstract][Full Text] [Related]
14. [Drug administration in renal insufficiency].
Mertz DP
Med Klin; 1980 Aug; 75(16):564-9. PubMed ID: 7412702
[No Abstract] [Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. [Therapy with opioids in liver or renal failure].
Tegeder I; Geisslinger G; Lötsch J
Schmerz; 1999 Jun; 13(3):183-95. PubMed ID: 12799931
[TBL] [Abstract][Full Text] [Related]
17. [The kidney and drugs. Disorders of the metabolism and kinetics of drugs in renal insufficiency].
Devulder B; Plouvier B; Lemaire P
Lille Med; 1976 Oct; 21(8):679-82. PubMed ID: 1004119
[No Abstract] [Full Text] [Related]
18. The biotransformation of drugs in renal failure.
Reidenberg MM
Am J Med; 1977 Apr; 62(4):482-5. PubMed ID: 851117
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
